Trial intelligence / Profile preview

Citalopram effects on esophageal sensitivity

NCT04355455Completed

Sponsor
UZ Leuven
Start
Jul 2011
Primary completion
Dec 2011
Modality
Small Molecules
01

Overview

Randomised trial in gastroesophageal reflux disease (GERD) comparing Citalopram with Placebo (2 arms). Primary endpoint: Change in sensitivity to thermal stimulation. Started Jul 2011; status: completed.

02

Drugs

citalopram
03

Conditions

gastroesophageal reflux disease (GERD)

Beyond the preview

Go deeper on NCT04355455.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04355455.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call